�Leading ovarian cancer researchers and clinicians from around the populace will fit in Seattle September forty-five to talk over exciting new discoveries and recent scientific findings to fight ovarian cancer, which kills more than 15,000 women every year. The news media will get a sneak peep at these discoveries during a good morning news conference on September 4.
"Early detection of ovarian genus Cancer is i of the most critical factors to improving the prognosis for women diagnosed with this disease," aforementioned Nancy Sclater, Executive Director of the Marsha Rivkin Center for Ovarian Cancer Research. "This symposium will reveal advances being made in early detection which will be critical while we search for a cure."
The two-day symposium will be held at the Pigott Auditorium on the campus of Seattle University and marks the beginning of Ovarian Cancer Awareness Month. More than 50 researchers will share their findings including the fact that ovarian malignant neoplastic disease may non even begin in the ovaries, novel research to use urine tests for early detecting, and modern strategies for improving dose penetration for patients diagnosed with ovarian cancer.
The symposium testament also feature four keynote addresses from some of the brightest names in ovarian cancer research. On Thursday, Christopher Crum, MD, from Harvard Medical School, will discuss the origins of ovarian cancer, and Anil K. Sood, MD, from University of Texas, MD Anderson Cancer Center, will present on the development of therapeutics.
Friday's keynote presentations will feature Maurie Markman, MD, as well from University of Texas, MD Anderson Cancer Center, who volition present his research on therapeutics. The last keynote address volition cover inquiry on familial ovarian cancer, presented by local and well-renowned researcher Mary-Claire King, PhD, from the University of Washington.
A news conference with the keynote speakers, Sclater and Dr. Saul Rivkin is scheduled to beginning the symposium at 9:30 a.m. on Thursday, Sept. 4. Details are below.
The Marsha Rivkin Center for Ovarian Cancer Research was founded in 1996 by Saul Rivkin, M.D., in memory of his wife world Health Organization succumbed to ovarian cancer. It has been the catalyst for national and international enquiry efforts aimed at finding solutions to ovarian cancer. The Center is consecrate to preservation lives and reducing woe through improved treatment, early detection and prevention of ovarian genus Cancer.
Marsha Rivkin Center for Ovarian Cancer Research
More information
Monday 1 September 2008
Subscribe to:
Posts (Atom)